Ferrante Marc, Geubel André P, Fevery Johan, Marogy Ghada, Horsmans Yves, Nevens Frederik
Department of Hepatology, University Hospital, Gasthuisberg, Leuven, Belgium.
Eur J Gastroenterol Hepatol. 2005 Nov;17(11):1247-53. doi: 10.1097/00042737-200511000-00016.
Hereditary hyperferritinaemia-cataract syndrome (HHCS) is a relatively rare disorder with an autosomal dominant trait. It can be caused by various mutations within the iron responsive element (IRE) of the L-ferritin gene. These mutations result in an increased translation of L-ferritin mRNA and consequently the accumulation of L-ferritin in different fluids and tissues. HHCS patients present with an isolated hyperferritinaemia in the absence of any sign of iron overload. Early onset bilateral cataract, probably due to accumulation of ferritin crystals in the lens, is the only presenting clinical manifestation. Internists, especially gastrohepatologists, should be aware of this syndrome and differentiate it from haemochromatosis which is much more frequent, in order to avoid unnecessary imaging procedures, liver biopsies and an eventual venesection therapy, which will only lead to microcytic anaemia. In the present paper we report the first cases with HHCS diagnosed in Belgium. At diagnosis, the seven known affected members of three different families had ferritin levels between 603 and 3432 microg/l (normal < 150 microg/l), and this in combination with normal iron and transferrin values. All of them were known with early-onset bilateral cataract and our postulated diagnosis of HHCS was confirmed after genetic sequencing of the L-ferritin gene, which showed a C39U point mutation in the first family, and an A40G point mutation in the IRE loop segment in the two other families. The other investigated members of the three families had normal ferritin values, no history of early-onset cataract and genetic analyses could not reveal a mutation in the IRE of their L-ferritin gene. In current clinical practice, gastroenterologists should remember that elevated ferritin levels in the absence of documented iron overload is not haemochromatosis.
遗传性高铁蛋白血症 - 白内障综合征(HHCS)是一种相对罕见的常染色体显性遗传病。它可由L - 铁蛋白基因铁反应元件(IRE)内的各种突变引起。这些突变导致L - 铁蛋白mRNA的翻译增加,进而导致L - 铁蛋白在不同体液和组织中积累。HHCS患者表现为单纯性高铁蛋白血症,无任何铁过载迹象。早期双侧白内障可能是由于晶状体中铁蛋白晶体的积累,是唯一出现的临床表现。内科医生,尤其是胃肠肝病学家,应了解这种综合征,并将其与更为常见的血色素沉着症区分开来,以避免不必要的影像学检查、肝活检及最终的放血治疗,因为这些只会导致小细胞性贫血。在本文中,我们报告了在比利时诊断出的首例HHCS病例。诊断时,三个不同家族的七名已知患病成员的铁蛋白水平在603至3432微克/升之间(正常<150微克/升),且铁和转铁蛋白值正常。他们均患有早发性双侧白内障,对L - 铁蛋白基因进行基因测序后证实了我们对HHCS的推测诊断,结果显示第一个家族存在C39U点突变,另外两个家族在IRE环段存在A40G点突变。这三个家族的其他受调查成员铁蛋白值正常,无早发性白内障病史,基因分析未发现其L - 铁蛋白基因的IRE中有突变。在当前临床实践中,胃肠病学家应记住,在无铁过载记录的情况下铁蛋白水平升高并非血色素沉着症。